Drugs & Targets Bristol-Myers Squibb and Rigel Pharmaceuticals enter collaboration February 27, 2015Vol.41 No.08
Drugs & Targets FDA grants breakthrough therapy designation to Rintega in glioblastoma February 27, 2015Vol.41 No.08
Drugs & Targets FDA Grants Accelerated Approval to Ibrance In HER2-Negative Metastatic Breast Cancer February 26, 2015Vol.38 No.02
Drugs & Targets FDA grants Orphan Drug Designation to doxorubicin formulation February 20, 2015Vol.41 No.07
Drugs & Targets FDA grants Orphan Drug Designation to Reolysin in pancreatic cancer February 20, 2015Vol.41 No.07
Drugs & Targets FDA expands indication for Revlimid to include multiple myeloma February 20, 2015Vol.41 No.07
Drugs & Targets E.U. Expands Velcade Label; ODAC to Examine Talimogene Laherparepvec in Melanoma February 13, 2015Vol.41 No.06
